Schadendorf, D. Long, G.V. Stroiakovski, D. Karaszewska, B. Hauschild, A. Levchenko, E. Chiarion-Sileni, V. Schachter, J. Garbe, C. Dutriaux, C. Gogas, H. Mandalà, M. Haanen, J.B.A.G. Lebbé, C. Mackiewicz, A. Rutkowski, P. Grob, J.-J. Nathan, P. Ribas, A. Davies, M.A. Zhang, Y. Kaper, M. Mookerjee, B. Legos, J.J. Flaherty, K.T. Robert, C., Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials, EUROPEAN JOURNAL OF CANCER, (82), 45-55, 2017, Elsevier Ireland Ltd,